FSBI “V.M. Bekhterev National Research Medical Center for Psychiatry and Neurology” of the Ministry of Health of the Russian Federation; FSBEI HE “Academician I.P. Pavlov First St. Petersburg State Medical University” of the Ministry of Healthcare of Russian Federation
Auto-generated profile, based on publicly available information
Alexander Olegovitch Kibitov
FSBI “V.M. Bekhterev National Research Medical Center for Psychiatry and Neurology” of the Ministry of Health of the Russian Federation; FSBEI HE “Academician I.P. Pavlov First St. Petersburg State Medical University” of the Ministry of Healthcare of Russian Federation
Госпитальная шкала тревоги и депрессии (Hospital Anxiety and Depression Scale, HADS) — широко применяемый инструмент для скрининга тревоги и депрессии, в том числе в практике врачей соматического профиля. Однако полноценная адаптация и валидация русскоязычной версии HADS для общей российской популяции до настоящего времени не проведена. ЦЕЛЬ ИССЛЕДОВАНИЯ Выполнить разработку, валидацию и оценку психометрических свойств адаптированной для российской популяции версии HADS. МАТЕРИАЛ И МЕТОДЫ Оценка психометрических свойств HADS проведена в выборке, включавшей 283 участника (77,4% женщин, средний возраст — 31,49 (9,066) лет), наличие психических расстройств выявлялось в ходе клинического интервью с использованием критериев МКБ-10. РЕЗУЛЬТАТЫ И ОБСУЖДЕНИЕ Факторный анализ подтвердил выраженную двухфакторную структуру HADS. Высокие значения альфы Кронбаха для всех вопросов HADS (α=0,90), а также для подшкал тревоги (α=0,86) и депрессии (α=0,84) свидетельствуют о хорошей внутренней согласованности опросника. На основании построения предиктивных моделей и проведения ROC-анализа предложены следующие оптимальные пороговые значения для выявления депрессии, тревоги и психических расстройств в целом: 9 баллов по подшкале депрессии, 10 баллов по подшкале тревоги и 18 баллов по общей шкале соответственно. ЗАКЛЮЧЕНИЕ Полученные результаты свидетельствуют о валидности и надежности русскоязычной версии HADS и позволяют рекомендовать ее для скрининга симптомов тревоги и депрессии в общей популяции, в том числе в рутинной практике врачей соматического профиля.
1 January 2019 in S.S. Korsakov Journal of Neurology and Psychiatry
We provide an overview of the recent achievements in psychiatric genetics research in the Russian Federation and present genotype-phenotype, population, epigenetic, cytogenetic, functional, ENIGMA, and pharmacogenetic studies, with an emphasis on genome-wide association studies. The genetic backgrounds of mental illnesses in the polyethnic and multicultural population of the Russian Federation are still understudied. Furthermore, genetic, genomic, and pharmacogenetic data from the Russian Federation are not adequately represented in the international scientific literature, are currently not available for meta-analyses and have never been compared with data from other populations. Most of these problems cannot be solved by individual centers working in isolation but warrant a truly collaborative effort that brings together all the major psychiatric genetic research centers in the Russian Federation in a national consortium. For this reason, we have established the Russian National Consortium for Psychiatric Genetics (RNCPG) with the aim to strengthen the power and rigor of psychiatric genetics research in the Russian Federation and enhance the international compatibility of this research.The consortium is set up as an open organization that will facilitate collaborations on complex biomedical research projects in human mental health in the Russian Federation and abroad. These projects will include genotyping, sequencing, transcriptome and epigenome analysis, metabolomics, and a wide array of other state-of-the-art analyses. Here, we discuss the challenges we face and the approaches we will take to unlock the huge potential that the Russian Federation holds for the worldwide psychiatric genetics community.
At least 50% of factors predisposing to alcohol dependence (AD) are genetic and women affected with this disorder present with more psychiatric comorbidities, probably indicating different genetic factors involved. We aimed to run a genome-wide association study (GWAS) followed by a bioinformatic functional annotation of associated genomic regions in patients with AD and eight related clinical measures. A genome-wide significant association of rs220677 with AD (p-value = 1.33 × 10−8 calculated with the Yates-corrected χ2 test under the assumption of dominant inheritance) was discovered in female patients. Associations of AD and related clinical measures with seven other single nucleotide polymorphisms listed in previous GWASs of psychiatric and addiction traits were differently replicated in male and female patients. The bioinformatic analysis showed that regulatory elements in the eight associated linkage disequilibrium blocks define the expression of 80 protein-coding genes. Nearly 68% of these and of 120 previously published coding genes associated with alcohol phenotypes directly interact in a single network, where BDNF is the most significant hub gene. This study indicates that several genes behind the pathogenesis of AD are different in male and female patients, but implicated molecular mechanisms are functionally connected. The study also reveals a central role of BDNF in the pathogenesis of AD.
Интернет-зависимость (ИЗ) признана одним из распространенных вариантов аддиктивных нарушений нехимической природы и имеет значительные негативные социальные, медицинские и экономические последствия. В ситуации, когда терапевтические подходы к ИЗ только разрабатываются, отсутствуют стандарты не только фармакологической, но и психолого-психотерапевтической помощи, особую актуальность приобретают комплексные, мультидисциплинарные исследования ИЗ, результаты которых крайне востребованы в целях профилактики и ранней диагностики заболевания. В результате анализа мировых научных данных в статье сформулирована базовая гипотеза и важнейшие цели комплексного междисциплинарного исследования для поиска и валидизации системы маркеров высокого риска развития ИЗ как клинического, биологического, генетического и психологического...
The negative impact of depression on the course and outcome of somatic disorders is well-known and has a solid theoretical basis. The analyses of prospective studies confirm the role of depression as an independent and significant risk factor for widespread chronic somatic disorders including such severe and life-threatening conditions as cardiovascular diseases, diabetes and oncological pathology. The majority of somatic disorders and depression are the part of the big class of hereditary diseases with multifactorial character and polygenic nature. It is likely, that the genetic risk diversity of these diseases in population is close. There is also a high probability of genetic risks levels overlap (or of common «cluster») of two or more diseases in one individual, with one disorder being major depression. In that case such diseases could be considered «genetically comorbid» and manifestation of one disease could alter the risks of other. Precise and informative diagnostic tools could detect subsyndromal depression that could be the prognostic sign of the high risk and rapid manifestation of somatic diseases. Thus, patients with depressive disorder could be considered as a group with high risks of diverse range of somatic pathology. The coalescence of fundamental biomedical scientists and internists (psychiatrists and other physicians) could lead to the elaboration of specific complex preventative measures including social ones. Keywords: depression, somatic diseases, hereditary disorders, risk factors, genetics, henetic risks, preventive medicine